(2R,3R)-2-Methylazetidin-3-ol hydrochloride

Catalog No.: 
ACOQHL213
CAS No.: 
2231664-90-5
Molecular Formula: 
C4H10ClNO
Molecular Weight: 
123.58
(2R,3R)-2-Methylazetidin-3-ol hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%
250mg98%
1g98%
5g98%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3R)-2-Methylazetidin-3-ol hydrochloride
IUPAC Name(2R,3R)-2-methylazetidin-3-ol hydrochloride
MDL No.MFCD31705457
Molecular FormulaC4H10ClNO
Molecular Weight123.58
SMILESO[C@H]1[C@@H](C)NC1.[H]Cl
InChI KeyVGWXJFDIRONLQP-VKKIDBQXSA-N
Synonym2231664-90-5 | (2R,3R)-2-methylazetidin-3-ol hydrochloride | cis-2-methylazetidin-3-ol hydrochloride | (2R,3R)-2-methylazetidin-3-ol | hydrochloride | 1354352-24-1 | (2R,3R)-2-METHYLAZETIDIN-3-OL HCL | rel-(2R,3R)-2-methylazetidin-3-ol hydrochloride | SCH
CAS No.2231664-90-5
PubChem CID134691792

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOQHL213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCIXG419 route compound structure diagram
    ACCIXG4191638744-75-8In Stock
  2. Then
  3. ACOQHL213 route product structure diagram
    ACOQHL2132231664-90-5In Stock
Inquiry

2. ACOQHL213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOQHL213 route product structure diagram
    ACOQHL2132231664-90-5In Stock
Inquiry

3. ACOQHL213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOQHL213 route product structure diagram
    ACOQHL2132231664-90-5In Stock
Inquiry

Comments (0)